Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3APS as add-on therapy in mild to moderate Alzheimer's Disease
NCT00217763Phase 3Unknown
- Sponsor
- GSK
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of tramiprosate in Alzheimer's disease (AD), sponsored by GSK. Status: unknown.
02
Drugs
tramiprosate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00217763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217763.